European Journal of Contraception and Reproductive Health Care最新文献_第4页

Do elevated thyrotropin levels increase the risk of miscarriages: yes or no? 促甲状腺激素水平升高会增加流产的风险吗?是还是否?

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2024-02-01 DOI: 10.1080/13625187.2023.2276031

Tatjana Barišić, Marjana Jerković Raguž, Ivona Šušak, Emil Babić, Svjetlana Grgić, Iva Mandić

{"title":"Do elevated thyrotropin levels increase the risk of miscarriages: yes or no?","authors":"Tatjana Barišić, Marjana Jerković Raguž, Ivona Šušak, Emil Babić, Svjetlana Grgić, Iva Mandić","doi":"10.1080/13625187.2023.2276031","DOIUrl":"10.1080/13625187.2023.2276031","url":null,"abstract":"Background: To examine correlation between elevated levels of thyrotropin with the frequency of miscarriages.Methods: A cross-sectional study was conducted on the 380 respondents and it investigated TSH (thyrotropin), thyroid peroxidase antibody(anti-TPO) and free thyroxine (FT4) in pregnant women who had a miscarriage (N = 179) and pregnant women with normal pregnancies (N = 201).Results: The incidence of subclinical hypothyroidism in the miscarriages group was higher than in control group (61.4% vrs 15.79% (p < 0.001). In the miscarriages group with hypothyroidism (first trimester) mean value of TSH was significantly higher 4.31 ± 2.55 mIU/L compared to the control group 1.95 ± 0.86mIU/L (p < 0.001). Logistic multivariate regression revealed that TSH and body mass index (BMI) have a significant influence on the miscarriage; TSH level has a higher odds ratio (OR) 1.47 CI (95% 1.22-1.78) than BMI (OR) 1.14 CI (95% 1.06-1.23)) (p < 0.001). The combination of thyroid autoimmunity and TSH > 2.5mIU/L increase the risk of miscarriage (65.75%) compared to positive anti-TPO antibodies and TSH < 2.5mIU/L(14.15%)(p < 0.001).Conclusions: Higher TSH levels correspond with obesity during early pregnancy and may be a sign of maternal thyroid dysfunction. Physiological thyroid function in the first trimester of pregnancy is important for perinatal outcome.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"107592659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Impact of a post-partum family planning intervention on contraception and fertility in Tanzania: two-year follow-up of a cluster-randomised controlled trial. 坦桑尼亚产后计划生育干预对避孕和生育的影响：分组随机对照试验的两年随访。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2024-02-01 DOI: 10.1080/13625187.2023.2290985

Julia K Rohr, Sarah Huber-Krum, Angelica Rugarabamu, Erin Pearson, Joel M Francis, Muqi Guo, Hellen Siril, Iqbal Shah, David Canning, Nzovu Ulenga, Till W Bärnighausen

{"title":"Impact of a post-partum family planning intervention on contraception and fertility in Tanzania: two-year follow-up of a cluster-randomised controlled trial.","authors":"Julia K Rohr, Sarah Huber-Krum, Angelica Rugarabamu, Erin Pearson, Joel M Francis, Muqi Guo, Hellen Siril, Iqbal Shah, David Canning, Nzovu Ulenga, Till W Bärnighausen","doi":"10.1080/13625187.2023.2290985","DOIUrl":"10.1080/13625187.2023.2290985","url":null,"abstract":"Purpose: We evaluate contraceptive use and pregnancy two years following an intervention in Tanzania, which provided antenatal post-partum family planning counselling and post-partum intrauterine device (PPIUD) services following delivery.Methods: We analyse data from five hospitals in Tanzania using a difference-in-difference cluster randomised design, with randomisation at the hospital level. We use women-level data collected at the index birth and a follow-up survey two years later among 6,410 women. Outcomes (overall modern contraceptive use, contraceptive type, pregnancy) are modelled with an intent-to-treat (ITT) approach using linear regression. We compare with the complier average causal effect (CACE) of the intervention among those counselled.Results: The intervention increased long-term PPIUD use by 5.8 percentage points (95% CI: 0.7-11.2%) through substitution away from other modern methods. There was no impact on overall modern contraceptive prevalence or pregnancy. Only 29% of women reported receiving PPIUD counselling. When accounting for this in the CACE analysis we saw a larger impact with 25.7% percentage point increase in PPIUD use (95% CI: 22.7-28.6%).Conclusion: The intervention provided women an additional contraceptive choice, resulting in higher use of PPIUD over two years. Increase in PPIUD use was brought about by shifting methods, not creating new modern contraceptive users.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139479552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Site necrosis at the insertion place of the single-rod subdermal contraceptive implant: report of five cases. 单棒皮下避孕植入物插入处局部坏死：附5例报告。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-12-01 Epub Date: 2023-11-30 DOI: 10.1080/13625187.2023.2269455

María D Faranna, Analía C Pesado

引用次数: 0

Statement of Retraction [A novel association between cytotoxin-associated gene A (CagA) positive strain of Helicobacter pylori and unexplained recurrent early pregnancy loss]. 收缩。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-12-01 Epub Date: 2023-11-30 DOI: 10.1080/13625187.2023.2284013

引用次数: 0

Knowledge, attitudes, and perceptions of health care providers regarding the recommendation and use of long-acting reversible contraceptive devices for adolescent patients. 卫生保健提供者对青少年患者推荐和使用长效可逆避孕装置的知识、态度和看法。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-12-01 Epub Date: 2023-11-30 DOI: 10.1080/13625187.2023.2272005

Fernando A Ávila-Sánchez, Daniela Sarria-Ortiz, Camilo Hernán Bonilla-Cortés, Laura Camila Solarte-Solarte, Catalina Cerón-Garcés, Laura Libreros-Peña, Evelyn E Peña-Zárate, Juan Sebastián Galindo-Sánchez, Annie Melissa Quintero, María Fernanda Escobar

{"title":"Knowledge, attitudes, and perceptions of health care providers regarding the recommendation and use of long-acting reversible contraceptive devices for adolescent patients.","authors":"Fernando A Ávila-Sánchez, Daniela Sarria-Ortiz, Camilo Hernán Bonilla-Cortés, Laura Camila Solarte-Solarte, Catalina Cerón-Garcés, Laura Libreros-Peña, Evelyn E Peña-Zárate, Juan Sebastián Galindo-Sánchez, Annie Melissa Quintero, María Fernanda Escobar","doi":"10.1080/13625187.2023.2272005","DOIUrl":"10.1080/13625187.2023.2272005","url":null,"abstract":"Objective: To describe the knowledge, attitudes, and perceptions of healthcare providers in a region in southwestern Colombia regarding the recommendation and use of long-acting reversible contraceptive (LARC) methods for adolescents.Study design: This was a cross-sectional study. An online exploratory survey was designed to assess healthcare providers' knowledge, attitudes, and perceptions of Valle del Cauca hospitals. For the development of this the questionnaire, a literature search and validation of the instrument's appearance were conducted.Results: The survey was completed by 115 people. Knowledge: 62.6% and 33% of the participants did not consider themselves capable of correctly placing an intrauterine device (IUD) or a subdermal implant, respectively. However, 73.9% of the participants had adequate theoretical knowledge. Attitudes: 64.3% of the participants considered that adolescents can acquire contraceptive methods without limitations. Short-acting reversible methods were the least recommended. Perceptions: For IUDs, 40.8% and 16.5% of the participants imposed a minimum age and minimum parity requirement for their use, respectively. Side effects were the main reason for not recommending in health institutions with a lower level of complexity.Conclusion: Healthcare providers had positive attitudes and adequate theoretical knowledge concerning to the effectiveness of LARCs. The main areas for improvement were practical knowledge about the insertion and proper use of the devices, indications for referral to gynaecologists for the insertion procedure, and concerns about side effects.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71428683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Menstrual cycle abnormalities in women: characteristics, perceptions, and health-seeking behaviours. 女性月经周期异常：特征、认知和寻求健康的行为。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-12-01 Epub Date: 2023-11-30 DOI: 10.1080/13625187.2023.2273753

Hülya Özberk, Dilek Bilgiç, Aysun Badem

{"title":"Menstrual cycle abnormalities in women: characteristics, perceptions, and health-seeking behaviours.","authors":"Hülya Özberk, Dilek Bilgiç, Aysun Badem","doi":"10.1080/13625187.2023.2273753","DOIUrl":"10.1080/13625187.2023.2273753","url":null,"abstract":"Objectives: To evaluate menstruation characteristics, perceptions, and health-seeking behaviours in women.Methods: We conducted this cross-sectional study with 394 women between February 2021 and October 2021. According to the self-perception of women, menstruation characteristics were divided into two groups, including 'normal' and 'abnormal'. The data were collected using the Personal Information Form, Assessment Form of the Menstrual Cycle Characteristics, and Health-Seeking Behaviour Scale.Results: Among all women, 49.7% perceived their menstruation characteristics as 'normal', and 50.3% perceived them as 'abnormal'. The menstruation characteristics negatively affected the daily life of 57.6% of women in the normal group and 68.7% of women in the abnormal group. Online health-seeking behaviour was the most common behaviour of seeking remedy; however, professional health-seeking behaviour was inadequate. Among women who perceived their menstruation characteristics as 'normal', excessive menstrual bleeding, extreme pain, and adverse effects on daily life increased health-seeking behaviour. Among women who perceived their menstruation characteristics as 'abnormal', irregular cycles, frequent bleeding, low levels of bleeding, the use of too many pads, extreme pain, and adverse effects on daily life increased health-seeking behaviour.Conclusion: The participants in this study exhibited insufficient health-seeking behaviour for abnormal menstruation characteristics. Women should be directed by health professionals to reliable online sources to seek help, and they should be encouraged to display professional health-seeking behaviour.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71428684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns. 一种新的单孕激素(POP):单螺环酮丸4mg 24 + 4对凝血指标和出血模式的影响。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-12-01 Epub Date: 2023-11-30 DOI: 10.1080/13625187.2023.2276668

Maurizio Guida, Luciano Quercitelli, Pasquale De Franciscis, Cinzia Ferrara, Marco Marietta, Mattia Iaccheri, Fabio Facchinetti, Filomena Capasso, Giovanni Grandi

{"title":"A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns.","authors":"Maurizio Guida, Luciano Quercitelli, Pasquale De Franciscis, Cinzia Ferrara, Marco Marietta, Mattia Iaccheri, Fabio Facchinetti, Filomena Capasso, Giovanni Grandi","doi":"10.1080/13625187.2023.2276668","DOIUrl":"10.1080/13625187.2023.2276668","url":null,"abstract":"Purpose: Progestin-only pills (POPs), compared to combined, are not associated with an increased risk of venous thromboembolism, but are associated with a poor cycle control. The aim of this study was to evaluate the impact of a new POP [4 mg drospirenone (DRSP) for 24 days with a 4-day hormone-free interval] on some coagulation markers (both procoagulant and fibrinolytic) and to describe its impact on bleeding patterns.Materials and methods: This is a prospective trial, based on serum evaluation of following coagulation markers and tests: Factor (F) X, F VIII, F V, INR, aPTT, Protein S and antithrombin III. A 'bleeding diary' was used to categorise women as having (1) unscheduled bleeding, (2) scheduled bleeding and (3) amenorrhoea. Thirty patients were followed for six 28-day intake cycles, with a follow-up at the end of the 3rd and 6th cycles.Results: There was a significant decrease of F X (p = 0.03) (-5.7% at cycle 6). No significant changes have been observed for F VII, F V and INR. A significant increase in aPTT (p = 0.01 at 3 cycles), Protein S (p = 0.0006 at 3 cycles) and antithrombin III (p < 0.0001 at 3 cycles) was recorded. This non-deteriorating coagulation impact was associated with a significant and progressive reduction of days of scheduled and unscheduled bleeding in users between cycles 4 and 6 (from 1.3 ± 0.2 days at cycle 4 to 0.8 ± 0.1 days at cycle 6 and from 2.6 ± 0.4 days at cycle 4 to 0.6 ± 0.2 days at cycle 6, respectively, p < 0.0001).Conclusions: DRSP 24 + 4 use was associated with a non-deteriorating effect on coagulation markers and a significant progressive reduction of days of scheduled and unscheduled bleeding.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92157218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Statement of Retraction [Ultrasound-guided versus uterine sound-sparing approach during copper intrauterine device insertion: a randomised clinical trial]. 超声引导与子宫保声入路在铜质宫内节育器置入中的对照:一项随机临床试验。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-12-01 Epub Date: 2023-11-30 DOI: 10.1080/13625187.2023.2286137

引用次数: 0

Oral hormonal therapy as treatment option for abnormal uterine bleeding. 口服激素治疗异常子宫出血的选择。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-12-01 Epub Date: 2023-11-30 DOI: 10.1080/13625187.2023.2270098

Chiara Selmi, Antonio La Marca

{"title":"Oral hormonal therapy as treatment option for abnormal uterine bleeding.","authors":"Chiara Selmi, Antonio La Marca","doi":"10.1080/13625187.2023.2270098","DOIUrl":"10.1080/13625187.2023.2270098","url":null,"abstract":"Background: abnormal uterine bleeding is a very frequent reason for referral to gynaecologists and can deeply influence the quality of life. Once organic causes requiring surgical treatment are ruled out, clinicians should be able to manage these patients conservatively in the most effective way.Materials and methods: a search in PubMed/MEDLINE database was conducted in order to find relevant and recent meaningful sources for this narrative review.Results: LNG-IUS 52 mg is the first-line treatment for non-organic causes. Nevertheless, it could be contraindicated or declined by the patient. Combined oral contraceptives (COC) and progestin-only pills inhibit the hypothalamic-pituitary-ovarian axis, preventing ovulation, and induce endometrial atrophy. Consequently, they are effective in treating AUB. Moreover, brand new pills containing a combination of oestrogens, progestins and GnRH antagonists are now available for the management of AUB related to uterine fibroids.Conclusions: In daily clinical practice, oral hormonal therapies are convenient and reversible tools to manage AUB when LNG-IUS 52 mg is contraindicated or turn down by the patient. Many oral hormonal therapies are prescribed to treat AUB, but only a few have been approved with this specific indication, therefore further large well-designed studies are necessary in order to compare the efficacy of different pills for treating AUB.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89720384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Statement of Retraction [Can Porphyromonas gingivalis be a novel aetiology for recurrent miscarriage?]. 缩回声明[牙龈卟啉单胞菌可能是复发性流产的新病因吗?]。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-12-01 Epub Date: 2023-11-30 DOI: 10.1080/13625187.2023.2283990

引用次数: 0